Articles about Bio Million

• Anthropic acquired Coefficient Bio, a startup founded eight months ago with fewer than 10 employees, for roughly $400 million in shares, despite it having no product or revenue. • The platform uses AI for pharmaceutical tasks like drug research planning and identifying new drug opportunities, positioning Anthropic's models for scientific discovery in life sciences. • This bet signals a strategic push into AI-driven biotech, potentially accelerating drug development amid growing competition in applied AI verticals.

• Anthropic acquired startup Coefficient Bio for more than $400 million to bolster its AI capabilities amid recent challenges like a source code leak. • The deal follows Anthropic's npm packaging error exposing Claude Code's source code, including memory architecture and model roadmap. • This acquisition strengthens Anthropic's position despite setbacks, potentially aiding future developments in autonomous AI features.